These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6668097

  • 1. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
    González-Martín G, Bravo I, Ibarra N, Arancibia A.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetic study of intravenous furosemide in nephrotic syndrome in children].
    Lenoir G, Halter D, Seligman R, Dreuz C.
    Arch Fr Pediatr; 1978 Feb; 35(2):187-97. PubMed ID: 637676
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of gentamicin in children with nephrotic syndrome.
    González-Martin G, Bravo I, Vargas H, Arancibia A.
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):555-8. PubMed ID: 3781676
    [Abstract] [Full Text] [Related]

  • 4. Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children.
    Prandota J.
    Dev Pharmacol Ther; 1982 Oct; 5(1-2):98-108. PubMed ID: 7151641
    [Abstract] [Full Text] [Related]

  • 5. [The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)].
    Rego Filho Ede A, Casoni W.
    Rev Bras Pesqui Med Biol; 1977 Oct; 10(5):299-304. PubMed ID: 594431
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
    Prandota J.
    Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics of orally administered furosemide in children with nephrotic syndrome].
    Prandota J.
    Pediatr Pol; 1982 Feb; 57(9):711-8. PubMed ID: 7170150
    [No Abstract] [Full Text] [Related]

  • 8. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML, Assael BM, Appiani AC, Edefonti A, Jusko WJ.
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [Abstract] [Full Text] [Related]

  • 9. Disposition and diuretic effect of furosemide in the nephrotic syndrome.
    Keller E, Hoppe-Seyler G, Schollmeyer P.
    Clin Pharmacol Ther; 1982 Oct; 32(4):442-9. PubMed ID: 7116760
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamics and pharmacokinetics of the basic triamterene analogue dimethylaminohydroxypropoxytriamterene.
    Priewer H, Kraft H, Mutschler E.
    Arzneimittelforschung; 1985 Oct; 35(11):1688-91. PubMed ID: 4091871
    [Abstract] [Full Text] [Related]

  • 11. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
    Na KY, Han JS, Kim YS, Ahn C, Kim S, Lee JS, Bae KS, Jang IJ, Shin SG, Huh W, Jeon US.
    J Korean Med Sci; 2001 Aug; 16(4):448-54. PubMed ID: 11511790
    [Abstract] [Full Text] [Related]

  • 12. Co-administration of albumin-furosemide in patients with the nephrotic syndrome.
    Ghafari A, Mehdizadeh A, Alavi-Darazam I, Rahimi E, Kargar C, Sepehrvand N.
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):471-5. PubMed ID: 21566302
    [Abstract] [Full Text] [Related]

  • 13. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome.
    Kühnel HJ, Günther K, Stein G, Hoffmann-Traeger A.
    Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):616-21. PubMed ID: 3429064
    [Abstract] [Full Text] [Related]

  • 15. Patterns of potassium wasting in response to stepwise combinations of diuretics in nephrotic syndrome.
    Haris A, Radó JP.
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):332-40. PubMed ID: 10442507
    [Abstract] [Full Text] [Related]

  • 16. [Furosemide--pharmacokinetics in geriatric patients with multimorbidity].
    Neubig E, Mühlberg W, Platt D.
    Z Gerontol; 1984 Jul; 17(5):251-60. PubMed ID: 6523981
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients.
    Nakahama H, Orita Y, Yamazaki M, Itoh S, Okuda T, Yamaji A, Miwa Y, Yanase M, Fukuhara Y, Kamada T.
    Nephron; 1988 Jul; 49(3):223-7. PubMed ID: 3398982
    [Abstract] [Full Text] [Related]

  • 18. The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
    Chay S, Woods WE, Rowse K, Nugent TE, Blake JW, Tobin T.
    Drug Metab Dispos; 1983 Jul; 11(3):226-31. PubMed ID: 6135581
    [Abstract] [Full Text] [Related]

  • 19. Diuretic effect and duration of action of a single intravenous dose of furosemide in uremia and myocardial infarction.
    Farghali H, Al Zuhair H, Al Windawi S, Al Hamdi A, Fariduddin M.
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):659-64. PubMed ID: 6526541
    [Abstract] [Full Text] [Related]

  • 20. Role of binding in distribution of furosemide: where is nonrenal clearance?
    Branch RA.
    Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.